drugset / Trial / NCT07305883

Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain

NCT07305883

Phase 3 Not yet recruiting 64 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to compare the analgesic effectiveness and side effects of intranasal ketorolac versus intranasal ketamine for reducing pain prior to digital nerve block procedures in patients with finger injuries in emergency department.

Timeline

Start
2025-12-28
Primary completion
2026-06-20
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 50 mg Intranasal
Subject Ketorolac Other / unclassified 30 mg Intranasal

Indications

No indication recorded.